| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing unmet needs in inflammatory bowel disease
|
Bokemeyer, Bernd
|
|
2015
|
20 |
9 |
p. 1037-1039
3 p.
|
artikel
|
| 2 |
Advances in measuring single-cell pharmacology in vivo
|
Vinegoni, Claudio
|
|
2015
|
20 |
9 |
p. 1087-1092
6 p.
|
artikel
|
| 3 |
An analysis of FDA-approved drugs for neurological disorders
|
Kinch, Michael S.
|
|
2015
|
20 |
9 |
p. 1040-1043
4 p.
|
artikel
|
| 4 |
Breaking free from chemical spreadsheets
|
Segall, Matthew
|
|
2015
|
20 |
9 |
p. 1093-1103
11 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2015
|
20 |
9 |
p. iii-
1 p.
|
artikel
|
| 6 |
Contents page 1
|
|
|
2015
|
20 |
9 |
p. i-
1 p.
|
artikel
|
| 7 |
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
|
Bauer, Renato A.
|
|
2015
|
20 |
9 |
p. 1061-1073
13 p.
|
artikel
|
| 8 |
Cyclodextrin nanoassemblies: a promising tool for drug delivery
|
Bonnet, Véronique
|
|
2015
|
20 |
9 |
p. 1120-1126
7 p.
|
artikel
|
| 9 |
Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents
|
Zhang, Shao-Lin
|
|
2015
|
20 |
9 |
p. 1112-1119
8 p.
|
artikel
|
| 10 |
Herbal drugs against cardiovascular disease: traditional medicine and modern development
|
Li, Lingjun
|
|
2015
|
20 |
9 |
p. 1074-1086
13 p.
|
artikel
|
| 11 |
Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome
|
Pereira, Lucília
|
|
2015
|
20 |
9 |
p. 1152-1158
7 p.
|
artikel
|
| 12 |
Integrated risk assessment of suicidal ideation and behavior in drug development
|
Muller, Patrick Y.
|
|
2015
|
20 |
9 |
p. 1135-1142
8 p.
|
artikel
|
| 13 |
Metal nanoparticles: a theranostic nanotool against cancer
|
Sharma, Harshita
|
|
2015
|
20 |
9 |
p. 1143-1151
9 p.
|
artikel
|
| 14 |
Patient-centered drug discovery as the means to improved R&D productivity
|
Raoof, Araz A.
|
|
2015
|
20 |
9 |
p. 1044-1048
5 p.
|
artikel
|
| 15 |
Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
|
Borch, Troels H.
|
|
2015
|
20 |
9 |
p. 1127-1134
8 p.
|
artikel
|
| 16 |
Successful generation of structural information for fragment-based drug discovery
|
Öster, Linda
|
|
2015
|
20 |
9 |
p. 1104-1111
8 p.
|
artikel
|
| 17 |
Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing
|
Kesharwani, Prashant
|
|
2015
|
20 |
9 |
p. 1049-1060
12 p.
|
artikel
|
Tijdschrift beschrijving